Rapid and sensitive techniques for identification and analysis of 'reactive-centre' mutants of C1-inhibitor proteins contained in type II hereditary angio-oedema plasmas
- PMID: 2244865
- PMCID: PMC1149599
- DOI: 10.1042/bj2710565
Rapid and sensitive techniques for identification and analysis of 'reactive-centre' mutants of C1-inhibitor proteins contained in type II hereditary angio-oedema plasmas
Abstract
Novel procedures for structural analysis of the 'reactive-centre' residues, particularly the P1 residue, of the dysfunctional C1-inhibitor proteins found in the plasmas of type II hereditary angio-oedema (HAE) patients are described. C1-inhibitor is adsorbed directly from plasma on to Sepharose-anti-(C1 inhibitor) beads. The P1 residue of C1 inhibitor is arginine and hence a potential cleavage site for trypsin. Thus trypsin digestion of the immobilized protein, followed by SDS/PAGE of the released fragments, identifies P1 residue mutations. Pseudomonas aeruginosa elastase digestion of the immobilized protein, followed by purification of the released C-terminal peptide (by h.p.l.c.) and N-terminal sequence analysis defines the new P1 residue (or other mutations in the reactive-centre region). The techniques are both rapid and highly sensitive, requiring only 400 microliters of plasma. In addition, they permit accurate assessment of the level of normal (functional) inhibitor in a subclass of type II HAE plasmas, those containing P1-residue mutant proteins.
Similar articles
-
Dysfunctional C1-inhibitor(At), isolated from a type II hereditary-angio-oedema plasma, contains a P1 'reactive centre' (Arg444----His) mutation.Biochem J. 1988 Jul 15;253(2):615-8. doi: 10.1042/bj2530615. Biochem J. 1988. PMID: 3178731 Free PMC article.
-
Identification of a new P1 residue mutation (444Arg----Ser) in a dysfunctional C1 inhibitor protein contained in a type II hereditary angioedema plasma.FEBS Lett. 1990 Jun 18;266(1-2):13-6. doi: 10.1016/0014-5793(90)81494-9. FEBS Lett. 1990. PMID: 2365061
-
Type II hereditary angio-oedema associated with two mutations in one allele of the C1-inhibitor gene around the reactive-site coding region.Hum Hered. 1992;42(5):298-301. doi: 10.1159/000154086. Hum Hered. 1992. PMID: 1459574
-
[Review of a new subtype of hereditary angio-oedema with normal complement C1-inhibitor].Ugeskr Laeger. 2018 Feb 5;180(6):V06170468. Ugeskr Laeger. 2018. PMID: 29429480 Review. Danish.
-
Molecular defects of the C1-inhibitor gene in hereditary angioedema.Behring Inst Mitt. 1989 Jul;(84):173-9. Behring Inst Mitt. 1989. PMID: 2572212 Review.
Cited by
-
The effect of C1 inhibitor on myocardial ischemia and reperfusion injury.Cardiovasc Pathol. 2013 Jan-Feb;22(1):75-80. doi: 10.1016/j.carpath.2012.05.003. Epub 2012 Jun 16. Cardiovasc Pathol. 2013. PMID: 22705194 Free PMC article.
-
Unique C1 inhibitor dysfunction in a kindred without angioedema. II. Identification of an Ala443-->Val substitution and functional analysis of the recombinant mutant protein.J Clin Invest. 1995 Mar;95(3):1299-305. doi: 10.1172/JCI117780. J Clin Invest. 1995. PMID: 7883978 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources